Overcoming Biosimilar Scaling Challenges.
| Publicado en: | Pharmaceutical Technology Vol. 49; no. 1; pp. 20 - 23 |
|---|---|
| Autor principal: | |
| Formato: | pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Jan/Feb2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=182588029&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 182588029 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15432521 4FK jtl: Pharmaceutical Technology issn: 15432521 maglogo: N pubinfo: dt: Jan/Feb2025 vid: 49 iid: 1 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 182588029 182588029 182588029 182588029 ppf: 20 ppct: 3 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Overcoming Biosimilar Scaling Challenges. aug: au: Challener, Cynthia A. sug: subj: Biosimilar Pharmaceuticals Economics Pharmaceutical Companies Standards Productivity Organizational Compliance Chemistry, Analytical Drug Approval United States Food and Drug Administration Marketing Drug Development Drug Packaging Recombinant Proteins Therapeutic Use Antibodies, Monoclonal Therapeutic Use Manufacturing Industry Standards Healthcare Supply Chain Economics Quality Assessment Diffusion of Innovation Manufacturing Industry Equipment and Supplies Strategic Planning Costs and Cost Analysis pubtype: Trade Publication doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|